Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2025-12-25 @ 4:04 PM
NCT ID: NCT00259857
Description: To make monthly phone calls to assess any side effects or adverse events.
Frequency Threshold: 0
Time Frame: two years
Study: NCT00259857
Study Brief: Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Gr-1:Yr-1/Yr-2: Alendronate/Pbo, Calcium, Vitamin D Group-1/Year-1, 11 participants will take Alendronate,(study medication) and calcium, and vitamin D (supplements) and in Year-2 they will crossover to placebo, calcium and vitamin D supplements. None None 0 11 0 11 View
Gr-2:Yr-1/Yr-2: Pbo/Alendronate, Calcium and Vitamin D Group-2/Year-1, 11 participants will take Placebo,and calcium, and vitamin D (supplements) and in Year-2 they will crossover to Alendronate (study medication), calcium and vitamin D (supplements). None None 0 11 0 11 View
Serious Events(If Any):
Other Events(If Any):